Wall Street closes at a record for the first time since end of January
LONDON - Smith & Nephew plc (LSE:SN, NYSE:SNN) announced that Thérèse Esperdy, its Senior Independent Director designate, will join the board of Rentokil Initial plc as a Non-Executive Director and Chair-designate, according to a press release statement.
Esperdy will be appointed to the Rentokil Initial board on July 1, 2026, and will assume the role of Chair of the Board on September 1, 2026. Rentokil Initial is listed on the London Stock Exchange.
The disclosure was made in accordance with UK Listing Rule 6.4.9R(2), which requires companies to announce when their directors take on additional board positions at other listed companies.
Smith & Nephew is a medical technology company focused on orthopedics, sports medicine, ENT, and advanced wound management. The company operates in more than 100 countries and reported annual sales of $6.2 billion in 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.